Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-10-10)Premium Content

Celgene Corporation (CELG)

2014-10-24@20:59:33 ET
Celgene CorporationCorporate Event Announcement Notice (WSH)

2014-10-24@16:42:31 ET
After Yesterday's Rally of 2.83% Shares Could Potentially Pullback (PSM)

2014-10-24@16:42:00 ET
Celgene Rises 2.83% on Heavy Volume: Watch For Potential Pullback (PSM)

2014-10-24@15:47:37 ET
Friday's ETF with Unusual Volume: BBH (MNV)

2014-10-24@15:11:57 ET
Shares of Celgene Rise to a New 52-Week High (F71)

2014-10-24@12:43:50 ET
Celgene Makes a Move: Up 1.5% (F77)

2014-10-24@10:29:03 ET
Celgene (CELG) Approaches New Upside Target of $104.28 (PSM)

2014-10-23@20:59:16 ET
Celgene CorporationCorporate Event Announcement Notice (WSH)

2014-10-23@08:56:22 ET
Sector Update: Health-Care Shares Higher Pre-Market (MID)

2014-10-23@08:55:44 ET
Sector Update: Health Care (MID)

2014-10-23@07:43:07 ET
Celgene Raises Guidance, but Remains In-line with Estimates (SEG)

2014-10-23@07:32:51 ET
Celgene Reports Third Quarter 2014 Operating and Financial Results (BIZ)

2014-10-22@15:14:41 ET
Shares of Celgene Have Risen Above Previous 52-Week High (F71)

2014-10-22@09:10:00 ET
New Medicare Plan, Clinical Study Results, ANDA Filing Confirmation, Strategic Collaboration, and Merger Termination - Research Reports on UnitedHealth, Celgene, Actavis, Bristol-Myers Squibb and Salix (PRN)

2014-10-21@19:18:51 ET
Phase II Data in Crohn's Disease for Celgene's Oral Antisense Therapy GED-0301 to Be Presented at UEG Week 2014 (ABW)

2014-10-21@14:36:30 ET
Celgene Trading Higher on 1.4x Above-Average Volume (CELG) (F82)

2014-10-21@13:47:36 ET
Celgene (CELG) Breaks Through Resistance at $93.51 (F79)